Latisse UK

latisse before
latisse after

This page is to provide information on Latisse UK.

Latisse is the trade name for a solution of bimatoprost that has been created for the treatment of hypotrichosis from a purely cosmetic perspective. Hypotrichosis is when a patient feels that they have inadequate or not enough eyelashes. By applying Latisse to the base of the eyelash, it causes it to grow longer, thicker and darker.

Latisse comes with disposable applicators and is in a small dropper bottle.

The makers were approved by the United States Federal Drugs Association (FDA) in 2008.

To gain FDA approval bimatoprost had to undergo studies into its safety and efficacy for this cosmetic application. It was found to be safe and effective at growing eyelashes. The average result was a 25% increase in length, 106% increase in thickness and 18% darker lashes.

A lot of press coverage has been generated on the potential for Latisse to cause iris discolouration. During the trials, no incident of iris discolouration has been demonstrated and, at the time of writing, Dr has found no evidence of this effect occurring in a cosmetic application. In 2010 alone, 1.5 million kits of Latisse were sold with no documented proof of iris changes. This does not mean that it cannot happen and if it were to happen, it is thought that the effect would be permanent.

Latisse is a registered trademark of Allergan Inc.